Trial Profile
An open label, 3-period fixed sequence study assessing pharmacokinetics of Doravirine in healthy subjects switched from Efavirenz
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2016
Price :
$35
*
At a glance
- Drugs Doravirine (Primary) ; Efavirenz
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 13 Dec 2016 New trial record
- 12 Nov 2016 Results published in the Antimicrobial Agents and Chemotherapy